SEC Filing Details

Document Details

Form
Filing Date
January 12, 2026
Document Date
January 8, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Trevi Therapeutics, Inc.
Issuer
Trevi Therapeutics, Inc.
Filer
HASTINGS DAVID C